A MedTech targeting early detection of esophageal cancer has raised £32.5m in Series B funding. Founded by experts at the University of Cambridge, Cyted Health is pioneering the development of minimally invasive cell collection coupled with proprietary biomarker discovery to transform the detection of pre-cancerous, cancerous and inflammatory esophageal conditions. The round was led by … Continue reading Cancer-fighting Cambridge spinout raises £32.5m